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I factors are LINE-like transposable elements in the
genome of Drosophila melanogaster. They normally
transpose infrequently but are activated in the germ-
line of female progeny of crosses between males of a
strain that contains complete elements, an I or inducer
strain and females of a strain that does not, an R or
reactive strain. This causes a phenomenon known as
I-R hybrid dysgenesis. We have previously shown that
the I factor promoter lies between nucleotides 1 and 30.
Here we demonstrate that expression of this promoter is
regulated by nucleotides 41-186 of the I factor. This
sequence can act as an enhancer as it stimulates
expression of the hsp7O promoter in ovaries in the
absence of heat-shock. Within this region there is a
site that is required for promoter activity and that is
recognized by a sequence-specific binding protein. We
propose that this protein contributes to the enhancer
activity of nucleotides 41-186 and that reduced I factor
expression in inducer strains is due to titration of this
protein or others that interact with it.
Keywords: Drosophila/I factor/transposable element
Introduction
Transposable elements make up a substantial proportion
of the genomes of most if not all eukaryotes including
man, usually comprising 10-15% of the total DNA. They
occur as families of dispersed repeat sequences and can
be classified according to their structure and presumed
mechanism of transposition. There are two main classes,
those elements that transpose by reverse transcription of
an RNA intermediate and those elements that transpose
directly from DNA to DNA (Finnegan, 1989b).
Elements that transpose via an RNA intermediate are
of two types, those that resemble retroviruses in having
long terminal direct repeats, namely LTRs and open
reading frames similar to gag, pol and, in some cases, env
and those that have no terminal repeats and end with
A-rich sequences at the 3' end of their coding strands.
The latter are often referred to as LINE-like elements as
the first examples to be detected were mammalian LINE,
or LI, elements. They usually have two open reading
frames, the second of which appears to encode a reverse
transcriptase. The I factor of Drosophila melanogaster is
of this type.
Transposable elements normally move infrequently.
Precise rates are difficult to determine but most transpos-
able elements in Drosophila are thought to transpose at a
rate of ~10--10-5 per generation (Charlesworth and
Langley, 1989). In several cases transposition is infrequent
because it is restricted by host or element-encoded factors.
Transposition of TyJ elements in yeast increases 10-fold
in strains carrying mutations in RAD6 (Picologlou et al.,
1990) and transposition of the retrovirus-like element
gypsy is increased in strains of D.melanogaster mutant in
flamenco (Pelisson et al., 1994; Prud'homme et al., 1995)
indicating involvement of host factors. Transposition of P
elements, on the other hand, is regulated by a protein
encoded by these elements themselves (Misra and Rio,
1990). Regulatory systems like these are likely to be
critical for the survival of a species as increased rates of
transposition result in reduced viability, reduced fertility
and increased frequencies of mutations.
Transposition of some elements has been shown to be
subject to a second level of regulation; in this case one
that restricts transposition to the germ-line. This may also
be evolutionarily advantageous for both the element and
its host since transposition events in somatic cells might
debilitate the individual in which they occur without
increasing the number of copies of the element transmitted
to the next generation. Host genes that regulate transpos-
able elements presumably also have roles to play in
the normal life of the organism concerned. A detailed
knowledge of mechanisms that control transposition
should therefore shed light on factors that control the
stability of eukaryotic genomes and allow transposable
elements to survive within them while at the same time
identifying genes that are important for the host.
The I factor is one of a number of LINE-like transpos-
able elements in D.melanogaster. Strains containing com-
plete and functional I factors are known as inducer, I,
strains while strains containing only incomplete and non-
functional elements are known as reactive, R, strains. I
factors are stable in the genome of an inducer strain but
are activated in the germ-line of female progeny of crosses
between inducer males and reactive females. This results
in reduced fertility and increased germ-line mutations
producing a syndrome known as I-R hybrid dysgenesis.
This phenomenon is restricted to females since the male
progeny of a dysgenic cross are normal and show no
increase in I factor transposition. The progeny of crosses
between reactive males and inducer females appear normal
even though I factor transposition can be detected in the
female progeny of such a cross at a frequency only ~5-
fold less than in dysgenic females (Picard, 1976).
Complete I factors are 5.4 kb long and contain two
open reading frames (Fawcett et al., 1986). The first,
ORFI, encodes a protein with a cysteine-rich motif similar
to that found in retroviral gag genes and we have shown
that it encodes a nucleic acid binding protein (A.Dawson,
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E.Hartswood, T.Paterson and D.J.Finnegan, manuscript in
preparation). The second, ORF2, encodes a protein with
some of the motifs characteristic of a retroviral pol gene
product and preliminary evidence indicates that it encodes
a reverse transcriptase (T.Paterson, A.Gabriel, J.D.Boeke
and D.J.Finnegan, unpublished data).
I factors transpose by reverse transcription of a full-
length RNA intermediate (Jensen and Heidmann, 1991;
Pelisson et al., 1991) that can only be detected in tissues
in which transposition takes place (Chaboissier et al.,
1990). Using constructs in which sequences at the
beginning of a complete I element were fused to a
chloramphenicol acetyl transferase (CAT) reporter gene
we have shown that the promoter for this RNA lies entirely
within the I element itself. The 5' boundary of this
promoter lies at nucleotide 1, where transcription is
initiated, while the 3' boundary is at about nucleotide 30
(McLean et al., 1993). Transcription from this promoter
is regulated in two ways. It is reduced in the presence of
complete I factors so that transposition is not seen in
an inducer strain and it is subject to tissue-specific regula-
tion restricting transcription to the female germ-line
(Chaboissier et al., 1990). A similar pattern of expression
is seen for the CAT gene if it is linked to nucleotides 1-
186 of the I factor that make up the 5' untranslated region
(McLean et al., 1993).
In this paper we demonstrate that an enhancer that
stimulates gene expression in ovarian nurse cells lies
between nucleotides 41 and 186. We also show that
nucleotides 138-157 are recognized by a sequence-specific
binding factor present in nuclear extracts of several tissues
including ovaries. These bases are required for full pro-
moter activity and for enhanced expression in ovaries,
suggesting that they are recognized by a transcription
factor. We propose that this factor, either on its own or in
conjunction with other proteins, is responsible for tissue-
specific control of I factor expression. We also suggest
that titration of this protein by complete I factors is
responsible for the reduced activity of I factors in
inducer strains.
Results
Tissue-specific control of I factor expression
We have identified sequences responsible for tissue-
specific expression of the I factor by measuring CAT
activity in ovaries and non-ovarian tissues (carcass) of
females from five lines of reactive flies transformed with
a P element containing the reporter element, 1-186::CAT.
This has nucleotides 1-186 of the I factor upstream of a
CAT gene with no other promoter. Although the absolute
levels of CAT activity in ovary and carcass vary from one
transformed line to another, presumably due to the effects
of adjacent sequences, there is more CAT activity in ovary
than carcass in each case with an average increase of -20-
fold (Table I and McLean et al., 1993).
We have mapped sequences responsible for this effect
by measuring the CAT activity in ovaries and carcass of
flies carrying deletion derivatives of the 1-186::CAT
construct. The results (Table I) indicate that increased
CAT activity in ovaries versus carcass requires sequences
lying between nucleotides 41-186 and is reduced 5-fold
if nucleotides 101-186 are deleted. This suggests that
there is an enhancer element active in ovaries that lies
between nucleotides 41 and 186 and that at least some of
the sequences required for this are between nucleotides
101 and 186.
In order to confirm that nucleotides 41-186 can act as
an enhancer we have introduced nucleotides 41-186
upstream of a minimal promoter for the heat shock gene
hsp7O linked to the Escherichia coli lacZ gene in a P
element transformation vector (Figure 1). Ovaries of
females from lines transformed with constructs having
nucleotides 41-186 inserted in either orientation were
stained for 0-galactosidase activity. The patterns of staining
seen in ovaries from these flies, as well as in ovaries from
control flies carrying the hsp7O-1acZ genes but without
any I factor insert are shown in Figure 2.
No f-galactosidase staining was seen in ovaries from
control flies (Figure 2A) whereas strong staining was seen
in the nurse cells of egg chambers at stages 8-10 in flies
carrying the reporter gene preceded by nucleotides 41-
186 in either orientation (Figure 2B and C). This confirms
Table I. The levels of CAT activity in ovary and carcass of females
from a reactive strain transformed with I factor promoter fragments
controlling expression of the Ecoli CAT gene
Promoter Line CAT activity
Ovary Carcass O/C
1-186 132 1807 75 24
137 1180 32 37
138 1604 282 5.7
143 2090 99 21
148 1740 144 12
20 ± 5.3
1-100 178 167 332 0.5
179 749 82 9.1
180 1008 476 2.1
183 920 269 3.4
184 291 74 3.9
3.8 + 1.4
1-40 177 39 249 0.16
185 181 193 0.94
0.55 ± 0.20
Activity is measured in pmol chloramphenicol acetylated per min per
mg protein. The last column shows the ratio of CAT activity measured
in extracts of ovary versus carcass together with the mean value for
this ratio for all transformed lines carrying the same construct.
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Fig. 1. Map of the I factor showing the regulatory region. (A) The
structure of a complete I factor showing the two open reading frames
(shaded boxes) and the 5'UTR (open box). (B) The 5'UTR showing
the region, nucleotides 41-186, including the ovarian enhancer
element and the transcription factor binding site, site 1. (C) Map of
the construct used to demonstrate the enhancer activity associated with
nucleotides 41-186. The 282-nucleotide hsp7O promoter fragment is
cross-hatched and the lacZ reporter gene is unshaded. The effect of the
I factor sequence has been tested in both orientations.
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Fig. 2. Nucleotides 41-186 of the I factor act as an ovary enhancer. Photomicrographs of ovarioles stained for f-galactosidase and coming from
reactive females carrying the hsp7O-lacZ reporter gene alone (A), or preceded by nucleotides 41-186 in the 5'-3' orientation (B), or 3-5'
orientation (C), in the absence of heat shock. (D) The staining of an ovariole from a female carrying the 41-186::hsp7O-IacZ construct after heat
shock.
that there is an enhancer in this region and that it stimulates
f-galactosidase expression in female germ cells late in
oogenesis. This pattern contrasts with that seen when
females from the same lines were heat shocked before
their ovaries were stained. In this case ,3-galactosidase
activity was detected in the somatic follicle cells (Figure
2D).
We have estimated the strength of this enhancer by
measuring 3-galactosidase activity in ovaries of flies from
each of two lines carrying these constructs. The level of
activity was ~14-fold greater in flies carrying the 41-186
fragment in the 5'-3' orientation than in flies carrying the
hsp70-lacZ vector alone (11- and 17-fold in the two lines
tested) and -6-fold greater for flies carrying it in the 3'-
5' orientation (5.4- and 5.8-fold in the lines tested). These
results confirm that the effects on CAT expression reported
in Table I and by McLean et al. (1993) are due to changes
in transcription rather than differential RNA stability, a
possible interpretation of results from I::CAT elements,
the transcripts of which contain some I factor sequences.
A sequence-specific binding factor recognizes
sequences within the enhancer
If nucleotides 41-186 contain sequences that regulate I
factor expression then these are probably recognized by a
transcription factor. We have tested for the presence of
such a factor in proteins extracted from the nuclei of
various tissues. Figure 3, lanes 5 and 6, shows that a
nuclear extract from ovaries of reactive females contains
Fig. 3. Sequence-specific binding of proteins to the I factor promoter
region. Nucleotides 1-186 labelled with 32p were mixed with nuclear
extracts and competitor DNA before electrophoresis. The extracts used
for each lane were as follows: lane 1, none; lanes 2-4, Schneider Line
2 tissue culture cells [SLf]; lanes 5-7, ovaries of reactive females
[OV(R)]; lanes 8-10, carcasses of reactive females [CAR(R)]; lanes 11-
13, reactive males [d(R)]; lanes 14-16, reactive females [9(R)]. No
competitor DNA was added to the binding reactions in lanes 2, 5, 8,
11 and 14. Cold 1-186 DNA was added to the binding reactions in
lanes 3, 6, 9, 12 and 15 (186). Cold 1-A186 DNA was added to the
binding reactions in lanes 4, 7, 10, 13 and 16 (A).
a sequence-specific binding factor that binds to a probe
comprising nucleotides 1-186. A preliminary DNase I
footprinting experiment suggested that this factor binds to
nucleotides 138-157, a region that we refer to as site
1. Further experiments have shown that the protected
sequence, ACAAAAACAACAAT, is somewhat smaller,
running from nucleotides 137 to 150 (Figure 4). This was
the only region that appeared to be protected by this extract.
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Fig. 4. Identification of site I by DNase I footprinting. A DNA
fragment comprising nucleotides 1-186 of the I factor was labelled
with 32P at the 3' end of the top strand. Track I shows a G + A
sequencing ladder prepared from this fraction. Lanes 2-4 show the
result of treating the labelled DNA with 0.005, 0.0015 and 0.025 units
of DNase I in the absence of protein. Lanes 5-7 show the result of
treating the labelled DNA with 0.1, 0.2 and 0.4 units of DNase I after
incubation with 3 ,ug of an ovarian nuclear extract. The position of the
protected sequence has been determined from the G + A sequencing
ladder.
We have investigated the occurrence of factors that
bind to site 1 in extracts from different tissues using gel
retardation experiments (Figure 3). In each case the
radioactive probe, nucleotides 1-186, was bound by a
factor, or factors, present in nuclear extracts from males
(lanes 11 and 12) and females (lanes 14 and 15) from a
reactive strain and from Drosophila tissue culture cells
(lanes 2 and 3). In females this factor was present in
extracts of both ovary and carcass (lanes 5, 6, 8 and 9).
Similar results were obtained with extracts from indi-
viduals of an inducer strain (data not shown).
Site 1 is the target of a sequence-specific binding factor
in each case, since nucleotides 1-186 cannot compete for
binding if site 1 is not present (Figure 3, lanes 4, 7, 10,
13 and 16) and binding can be competed by a double-
stranded oligonucleotide comprising the sequence of site
1 (Figure 5, lanes 5 and 9). We have also shown that
there is no detectable binding to a 1-186 probe from
which site 1 has been deleted (data not shown).
Three retarded bands, bands 1-3, could be seen when
the 1-186 probe was treated with nuclear extracts from
males or female carcasses or ovaries (Figure 3). Band 3
was not detected with some extracts of whole females or
ovaries but was the only band detected with extracts of
tissue-culture nuclei which also yielded some retarded
probe at a higher molecular weight. These three bands
- 186 A 0 - 186 a 0
EXTRACT
COMPETITOR
Fig. 5. Nucleotides 138-157 are a target for a sequence-specific
binding factor. Nucleotides 1-186 labelled with 32P were mixed with
protein extracts and competitor DNA before electrophoresis. The
extracts used for each lane were as follows: lane 1, none; lanes 2-5,
Schneider Line 2 tissue culture cell [SL2]; lanes 6-9, carcasses of
reactive females [CAR(R)I. No competitor DNA was added to the
binding reactions in lanes 2 and 6. Unlabelled 1-186 DNA was added
to the binding reactions in lanes 3 and 7 (186). Unlabelled I-A186
DNA was added to the binding reactions in lanes 4 and 9 (A). An
unlabelled oligonucleotide comprising nucleotides 138-157 was added
as competitor to the binding reactions in lanes 5 and 9 (0).
must be due to the binding of different proteins or different
forms or amounts of the same protein. Whichever is the
case, these bands are due to factors binding to site 1 since
they were eliminated when an excess of intact unlabelled
1-186 DNA was used as a competitor but only if nucleo-
tides 138-157 were present. Differences between extracts
may reflect differences in the concentration of binding
factor.
Site 1 is part of the I factor ovarian enhancer
Since we have shown that nucleotides 101-186 are
required for enhanced expression of the I factor promoter
in ovaries, it is tempting to suggest that site 1 is part of
the enhancer. We have investigated whether or not this is
the case by measuring CAT activity in ovaries and carcass
of reactive females transformed with the CAT gene under
the control of nucleotides 1-186 but with site 1 deleted
(1-A186). Table II shows that deletion of this 20-nucleotide
sequence has a dramatic effect, reducing both the absolute
level of CAT expression in both tissues and the level in
ovaries as compared with carcass. These results indicate
that site 1 is indeed required for enhancer activity.
Effect of the inducer state on the I factor promoter
We have tried to map sequences responsible for the
reduced expression of the I factor promoter in inducer
strains by making inducer derivatives of each of the
reactive strains that carry nucleotides 1-186 or 1-100
linked to the CAT reporter gene. Table III shows the levels
of CAT activity in ovaries and carcass in the reactive
and inducer backgrounds and that there is a significant
reduction in CAT expression in ovaries of inducer as
compared with reactive flies with an average difference
of ~30-fold. This effect is greatly reduced if nucleotides
101-186 are deleted as the difference for flies with this
construct is only -4-fold. Interestingly the inducer state
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Table II. The levels of CAT activity in ovary and carcass of females
from a reactive strain transformed with the CAT gene under the
control of nucleotides 1-186 but with site 1 (nucleotides 138-157)
deleted, together with the ratio of the activity in ovary versus carcass
Promoter Line CAT activity
Ovary Carcass O/C
I-A186 9 3.2 9.4 0.34
1 1 1.8 5.0 0.36
13 2.9 7.7 0.38
14 0.42 2.1 0.2
17 0.58 0.95 0.61
0.38 ± 0.07
The mean value for this ratio in the five lines tested is also given.
has little effect on expression of CAT in carcass tissue
whichever promoter fragment is used.
These results demonstrate that nucleotides 101-186 not
only contain the ovary enhancer but also are responsible
for at least part of the inhibition of expression that is seen
in an inducer strain.
Discussion
Although complete I factors are present in the genomes
of inducer strains high levels of I factor expression are
only seen in the female progeny of a dysgenic cross and
then only in their ovaries. This reflects two levels of
transcriptional regulation, one that results in higher levels
of transcription in ovaries than in female carcass or males,
and another that reduces expression in females of an
inducer as compared with a reactive strain. We have found
that at least some of the sequences responsible for both
levels of control are located between nucleotides 41 and
186. Within this region we have identified an enhancer
responsible for increased expression in ovaries. This
requires site 1 for its activity and we have shown that this
sequence is recognized by a sequence-specific binding
factor, or factors, present in one form or another in
males, female carcass and ovary and Drosophila tissue
culture cells.
Within ovaries this enhancer stimulates expression in
germ-line nurse cells but not in somatic follicle cells. This
effect is greatest in egg chambers at stages 8-10. These
results are similar to those reported by Lachaumme et al.
(1992) and Tatout et al. (1994) who studied f-galactosidase
expression in reactive females carrying a translational
fusion of ORFI of the I factor (nucleotides 1-290/1014-
1104) and the lacZ gene. They also detected expression
in nurse cells and not follicle cells but could detect
f-galactosidase staining as early as stage 2. The reason
for this difference is not clear but may be due to the
number of copies of the transgene present since Tatout
et al. (1994) found that they could detect 0-galactosidase
in the germaria of ovarioles of females with four copies
of their construct.
The sequence-specific binding factor, or factors, recog-
nizing site 1 stimulates I factor expression since this is
reduced if site 1 is deleted (Table II). We presume that
this factor affects transcription although we have not
demonstrated this directly. Since nurse cells are actively
synthesizing host RNA and proteins that are transported
Table III. The levels of CAT activity of isogenic reactive ad inducer
females carrying the CAT gene under the control of the I factor
promoter
Promoter Line Ovary Carcass
CAT RiI CAT R/I
1-186 132' 269 6.7 67 1.1
137' 14 84 17 1.9
138' 157 10 167 1.7
143' 99 21 78 1.3
148' 77 23 129 1.1
29 ± 14 1.4 0.36
1-100 1781 113 1.5 188 1.8
1791 261 2.9 65 1.3
180' 95 10 227 2.1
183' 325 2.8 180 1.5
184' 189 1.5 67 1.1
3.7 + 1.6 1.6 + 0.18
Each row indicates the CAT activity for ovary and carcass in females
from inducer derivatives of the 1-186 and 1-100 transformants shown
in Table I. The ratios of the activity in the reactive versus the inducer
background (R/1) are give for each tissue together with the mean
values for all transformants carrying the same construct.
to oocytes in preparation for embryogenesis, it is likely
that this factor normally functions to stimulate expression
of genes coding for some of these products and it may be
essential for female fertility. We are trying to identify site
1 binding proteins by molecular and genetic means so
that we test this directly.
Although the concentration of site 1 binding protein is
similar in all tissues (Figure 3) it only enhances the
activity of the I factor promoter in ovaries. This may be
because it is only in this tissue that it is modified
appropriately. Alternatively the activity of site 1 binding
protein may require interaction with another protein that
is restricted to the female germ-line. If this protein does
not itself bind DNA, but interacts with it only through its
association with site 1 binding protein, then it would have
escaped detection in our DNA binding assays.
The mechanism responsible for tissue-specific expres-
sion of the I factor contrasts with that utilized by P factors,
the transposable elements responsible for P-M hybrid
dysgenesis, although in each case host-encoded proteins
are involved. Transposition of P factors is restricted to
the germ-line because a splicing factor inhibits removal
of the third intron of the transposase gene in the soma
(Siebel and Rio, 1990; Siebel et al., 1994) whereas I
factors exploit a tissue-specific transcription factor.
The activity of another Drosophila transposable ele-
ment, hobo, is also restricted to the germ-line because of
a transcriptional control (Calvi and Gelbart, 1994). We
can detect no similarity between site 1 and the promoter
region of hobo suggesting that these elements utilize
different germ-line-specific transcription factors. This is
not surprising as hobo is active in both sexes unlike I
factors that are only active in females.
Although we have been unable to detect any protein
binding the I factor promoter other than to site 1, we
believe that there may be complex interactions regulating
I factor expression. Deletion of nucleotides 101-186
removes site 1 and reduces expression from the I factor
promoter in ovaries by ~.-5-fold (Table I) whereas deletion
of site 1 alone has a more extreme effect, lowering
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expression in ovaries 100- to 1000-fold and in carcass,
10- to 100-fold (Table II). This may change the spacing of
other regulatory factors in this region, cause inappropriate
phasing of nucleosomes or allow some residual binding
of site 1 binding factor, or of an associated protein so that
transcription is inhibited. It is also possible that deletion
of site 1 affects translation of I::CAT RNA.
The differences between an inducer and a reactive strain
are due to the presence of one or more complete I factors
since a reactive strain can be converted to the inducer
state simply by the introduction of a functional I factor
(Pritchard et al., 1988). When this is done, either by
transformation or by a dysgenic cross, the copy number
of the I factors increases as a result of transposition until
it reaches a stable state that must reflect some form
of auto-regulation (Pelisson and Bregliano, 1987). The
product of ORF2 cannot be involved since females of a
reactive strain carrying an I factor mutant in this gene do
not produce dysgenic progeny when crossed with inducer
males (Jensen et al., 1995) indicating that this mutant
element can regulate I factor expression. This could be
mediated by the product of ORFI as has been suggested
previously (Fawcett et al., 1986; Finnegan, 1989a; Busseau
et al., 1994), although we have been unable to detect any
ability of this protein to bind specifically to nucleotides
1-186 (A.Dawson, E.Hartswood, T.Paterson and D.J.
Finnegan, manuscript in preparation), a region that we
have found to be sensitive to the presence of complete I
factors (Table III and McLean et al., 1993). The effect on
I factor expression of an element with a mutation in ORFI
has not been reported and ORFI protein could have an
effect by interacting with some other DNA sequence or
with I factor RNA.
If it is not an I factor-encoded protein that reduces
expression of the I factor promoter in inducer strains then
maybe it is I factor DNA itself. One possible mechanism
would be titration of a factor necessary for I factor
expression. This could be site 1 binding protein itself, as
we shall assume in the discussion that follows, or a protein
interacting with it.
When a complete I factor is introduced into a reactive
strain it finds itself, in female germ cells, in a permissive
environment with a level of site 1 binding protein that
allows transcription and transposition. The resulting
increase in the number of copies of site 1 might then
titrate this protein until it reaches a point at which
transcription falls below the level required for transposition
and hybrid dysgenesis.
This mechanism can account for the stimulation of
transposition seen in the female progeny of a dysgenic
cross since they contain about one half the number of
complete I factors present in the parental inducer strain.
This might reduce the ratio of site 1 DNA to site 1 binding
protein sufficiently to allow transposition. This model
predicts that we should be able to create a strain that does
not permit I factor transcription and transposition simply
by introducing into a reactive strain multiple copies of
site 1 without any coding sequences. We are testing this
proposal.
Should these ideas concerning the regulation of! factor
transposition prove to be correct, then this element is
maintained because it takes advantage of host factors both
to limit its activity to the germ-line and to maintain its
copy number at a level that is not deleterious to the host
but sufficient to ensure its long term survival. This is
similar to the mechanism that regulates the expression of
P elements that are responsible for P-M hybrid dysgenesis
since these also utilize a single host factor for both aspects
of their regulation. Expression of P elements is limited to
the germ-line and is only seen in the progeny of a dysgenic
cross. In this case tissue-specific control is regulated post-
transcriptionally by a tissue-specific splicing event (Laski
et al., 1988; Roche et al., 1995) while expression is
limited to dysgenic flies because transcription from the P
element promoter only occurs at high levels in these
individuals (Misra and Rio, 1990). These apparently
different regulatory mechanisms are linked in that they
result from different levels of a particular splicing factor
in somatic and germ cells (Siebel et al., 1994; Roche
et al., 1995). This factor prevents splicing of the third
intron of the transposase gene. If this intron is not removed
from P factor transcripts then they direct synthesis of a
repressor that reduces transcription from the P promoter.
It is the ratio of the splicing factor to P transcripts that
determines whether transposase or repressor is produced
(Ronseray et al., 1993; Roche et al., 1995).
We believe that the two aspects of I factor control are
also linked. In this case transcription is restricted to the
female germ-line by a tissue-specific transcription factor
and is reduced in inducer stains because of changes in the
ratio of this factor and its binding site.
Materials and methods
Construction of l::CAT reporter elements
P-element transformation vectors carrying fragments of the I factor
promoter linked to the CAT gene and a polyadenylation signal from
SV40 (see McLean et al., 1993 for details) were constructed by ligating
PstI fragments containing these sequences to the PstI site of pW8
(Klemenz et al., 1987) so that transcription from the I factor promoter
would be in the opposite direction to that from both the white gene and
the promoter of the transformation vector.
Plasmid pl-AI86 containing the I factor promoter with an internal
deletion of nucleotides 139-157 was constructed as described by McLean
et al. (1993) for 3' deletions. The internal deletion of the promoter
fragment was synthesized by the PCR using an oligonucleotide primer
with an XbaI site at its 5' end for the plus strand primer and a primer
with a BamHI site at its 5' end for the minus strand. In this case, the
minus strand primer was designed so that it contained the sequence
complementary to nucleotides 186-128 but with nucleotides 139-
157 deleted.
Construction of l-lacZ reporter elements
The fragments to be tested for enhancer activity were obtained by PCR
using primers with XhoI sites at their 5' ends. A fragment containing
nucleotides 41-186 of the I factor promoter was generated using primers
CTCGAGCAGTCTAAAGCCTCGTTCGC for the left-hand end and
CTCGAGGATTGTTGGTTAAGGGCTTG for the right-hand end. This
was inserted into the XhoI site of pERI vector (Ronaldson and Bownes,
1995) in either orientation just upstream of a minimal hsp7O promoter
upstream of the E.coli lacZ gene (Figure 1). This plasmid contains a
282-nucleotide XhoI-PstI fragment from the promoter region of the
hsp7O gene inserted upstream of the lacZ gene in the P transformation
vector pCaSpeR-AUG-,Bgal (Thummel et al., 1988).
P element mediated transformation
The DNA used for transformation of Drosophila was prepared using
QIAGENTM columns and was performed by embryo injection as described
by Rubin and Spradling (1982). Transposase activity was provided by
the helper plasmid phs7OA2-3wc (McLean et al., 1993) and the recipient
embryos were from the reactive strain WK (Luning, 1981). Adults coming
from injected embryos were crossed with WZK virgins of the opposite sex
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and their progeny were examined for a coloured eye phenotype.
Homozygous lines were established from any such flies by sibling
mating and we have confirmed by Southern blotting that each line used
contains a single copy of the transgene.
Inducer derivatives of reactive lines were made by the crossing scheme
described by McLean et al. (1993).
CAT assays of Drosophila tissues
Extracts were prepared from 100 4- to 5-day old male or female flies,
100 pairs of ovaries or 100 female carcass tissues. These tissues were
homogenized in 500 ,ul 0.25 M Tris-HCI pH 7.8. The homogenate was
passed through five freeze-thaw cycles and then heated to 65°C for
5 min to inactivate proteins that interfere with the CAT assay. The
extract was then spun in a microfuge to pellet cell debris and denatured
proteins. The concentration of protein was measured by the Bradford
method (Bradford, 1976; Read and Northcote, 1981).
One microgram of extract was mixed with 2 1g 25 mM acetyl
coenzyme A, 0.5 gl D-threo-[dichloroacetyl-1-14C]chloramphenicol
(53 mCi/mmol). The volume was made up to 40 gi with water and the
reaction incubated at 37°C for 1 h. The reaction was then stopped and
extracted by vortexing with 200 ,ul of ethyl acetate for I min. The
organic phase was separated by centrifugation in a microfuge for 2 min
and was transferred to a new tube and the ethyl acetate allowed to
evaporate overnight on bench. Twenty microlitres of fresh ethyl acetate
was then added to the tube and vortexed. Acetylated and unacetylated
forms of chloramphenicol were separated by silica gel TLC on Merck's
TLC silica matrix. The CAT activity was then measured using a
Phosphorlmager (Molecular Dynamics) and expressed as the number of
pmoles of [14C]chloramphenicol acetylated per min per mg of protein.
Preparation of nuclear extracts from Drosophila tissues
The method for preparation of nuclear extracts described by Frank et al.
(1992) was followed with some modifications. About 500 ovaries from
3- to 4-day old flies were dissected in Ringer's solution. Egg chambers
were separated by gently pipetting up and down and were collected by
centrifugation at 400 g for 7 min at 4°C. The supernatant was removed
and the egg chambers washed in 135 mM NaCl, 5 mM KCI, I mM
CaC12, 0.5 mM MgCl2, 1.5 mM Na2HPO4 and 2.5 mM Tris pH 7.5.
The centrifugation was repeated to collect intact egg chambers that were
next resuspended in two volumes of 10 mM HEPES pH 7.9, 10 mM
KCI, 1.5 mM MgC12, 0.5 mM DTT and 0.5 mM PMSF. The egg chambers
were then homogenized thoroughly with a motorized homogenizer and
centrifuged at 1400 g for 4 min at 4°C. The pellet was resuspended in
an equal volume of 10 mM HEPES pH 7.9, 400 mM NaCl, 1.5 mM
MgCl2, 0.5 mM DTr, 0.5 mM PMSF and 5% glycerol, then 5 M NaCl
was added to a final concentration of 0.35 M and incubated on ice for
30 min. The nuclear extract was obtained by high speed centrifugation
at 25 500 g overnight at 4°C. Glycerol was added to the supernatant, to
a final concentration of 20% and the extract stored in 20 g1 aliquots at
-70°C. The protein concentration of the extract was determined by the
Bradford method. Extracts of other tissues were prepared in a similar way.
Gel retardation assays
Gel retardation was performed as described by Soeller et al. (1988).
Three micrograms of Drosophila nuclear extract were incubated with 1 gg
of non-specific competitor DNA [poly(dI-dC), Boehringer Mannheim] on
ice in a 10 ,ul reaction volume containing 25 mM HEPES pH 7.6, 40
mM KCI, 2 mM MgCl2, 0.1 mM EDTA, 1 mM DTT and 10% glycerol
for 10 min. About one nanogram of end-labelled probe DNA was then
added to the reaction and the incubation continued on ice for a further
20 min. In competition assays, a 100-fold molar excess of unlabelled
DNA was added to the reaction 10 min before the labelled probe. DNA-
protein complexes were resolved on 5% polyacrylamide gels in I X TBE
and the position of the probe detected by autoradiography. Extracts were
made from the isogenic reactive and inducer strains Charolles and
Charolle RC+ (Pe1isson and Bregliano, 1987) and Schneider Line 2
tissue-culture cells (Schneider, 1972).
DNase I footprinting
DNase I footprinting assays were carried out as described by Leblanc
and Moss (1994). The DNA to be protected was a 196 nucleotide Pstl-
BamHI fragment including nucleotides 1-186 of the I factor. This was
labelled with 32P at the 3' end of the top strand using Klenow DNA
polymerase. The binding reaction was performed as described for gel
retardation. Binding buffer was then added to make a total volume of
50 1g. The reaction tube was transferred to room temperature and 50 ,ul
of cofactor solution (10 mM MgCI2, 5 mM CaCI2) was added. Five
microlitres of the appropriate dilution of DNase I were then added. After
2 min of digestion, the reaction was stopped by the addition of 100 PIl
of stop solution (1Y% SDS, 200 mM NaCI, 20 mM EDTA pH 8.0 and
40 mg/ml tRNA). The reaction was then extracted with an equal volume
of phenol/chloroform (1:1) and DNA precipitated from the aqueous
phase with ethanol. The DNA pellet was washed with 70% ethanol,
dissolved in 5 RI sequencing loading buffer, denatured by boiling for
2 min and then the fragments separated on a 6% acrylamide sequencing
gel. A G + A sequencing ladder prepared from the same fragment as
used for the footprint was run in parallel with the sample as a marker.
f/-galactosidase staining and enzyme assay
Drosophila tissues were dissected from 2- to 3-day old flies in Ringer's
solution. Dissected tissues were left to stain overnight at 37°C in 100 PI
of staining buffer solution (10 mM Na,HPO4, 150 mM NaCI, I mM
MgCI2, 7 mM potassium ferrocyanide, 7 mM potassium ferricyanide
and 0.2% X-Gal). The stained ovaries were fixed in 4% formaldehyde
in Ix PBS for 15 min and then washed in lX PBS for 30 min before
mounting. Tissues expressing the reporter gene were detected by their
blue colour. Heat treatment was performed by placing flies at 37°C for
1 h followed by a recovery period of 2- to 3 h at 18°C before dissection.
For quantitative assays of ,-galactosidase activity, ovaries were
dissected from 10 flies and were homogenized thoroughly in 500 Pl of
cold homogenization buffer (60 mM Na2HPO4, 40 mM NaH2PO4,
10 mM KCI, 1 mM MgSO4, 50 mM ,B-mercaptoethanol). Samples were
centrifuged at 12 000 r.p.m. for 5 min. Four hundred microlitres of
supernatant was pre-incubated at 37°C for 5 min before 600 pl of
o-nitrophenyl-f-galactopyranoside (ONPG) was added and the incubation
continued at 37°C. The enzyme reaction was followed by measuring
OD42Onm at 10 min time intervals. The protein concentration of each
sample was determined by the Bradford method. The f3-galactosidase
activity of each construct was measured as OD420X 102/min/mg protein.
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